Sanara MedTech Inc.
SMTI · NASDAQ
Bulios Fair Price
$24.41
30.6% downside
Current Price
$35.17
According to Bulios Fair Price, SMTI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Sanara MedTech Inc. is an American company focused on the development, manufacturing, and distribution of medical products for the treatment of chronic wounds and wound infections. Their portfolio includes a wide range of products, including dressings, hydrogels, creams, and other medical preparations that aid in wound healing and minimize the risk of infection. Sanara MedTech focuses on innovative therapeutic approaches and technologies that provide effective and gentle solutions for patients with chronic wounds or wounds caused by injuries or surgical procedures. Their products are designed to provide optimal support for healing and minimize the time needed for patient recovery.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Seth D. Yon
Employees
108
Headquarters
Fort Worth
Upcoming events
Earnings
Upcoming earnings report
Ex-Dividend
Ex-dividend date